GR77560B - - Google Patents

Info

Publication number
GR77560B
GR77560B GR72073A GR830172073A GR77560B GR 77560 B GR77560 B GR 77560B GR 72073 A GR72073 A GR 72073A GR 830172073 A GR830172073 A GR 830172073A GR 77560 B GR77560 B GR 77560B
Authority
GR
Greece
Application number
GR72073A
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of GR77560B publication Critical patent/GR77560B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/72—4,7-Endo-alkylene-iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/72—4,7-Endo-alkylene-iso-indoles
    • C07D209/76—4,7-Endo-alkylene-iso-indoles with oxygen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR72073A 1982-07-28 1983-07-28 GR77560B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40249482A 1982-07-28 1982-07-28

Publications (1)

Publication Number Publication Date
GR77560B true GR77560B (el) 1984-09-24

Family

ID=23592140

Family Applications (1)

Application Number Title Priority Date Filing Date
GR72073A GR77560B (el) 1982-07-28 1983-07-28

Country Status (14)

Country Link
EP (1) EP0100426A1 (el)
JP (1) JPS5933261A (el)
KR (1) KR840005424A (el)
AU (1) AU1734183A (el)
DK (1) DK344083A (el)
ES (1) ES8504125A1 (el)
FI (1) FI832716A7 (el)
GR (1) GR77560B (el)
IL (1) IL69150A0 (el)
NO (1) NO832734L (el)
PH (1) PH18828A (el)
PL (1) PL243202A1 (el)
PT (1) PT77114B (el)
ZA (1) ZA835505B (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200801825B (en) 2005-07-27 2009-12-30 Dov Pharmaceutical Inc Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: Preparation and use to treat neuropsychiatric disorders
KR101294014B1 (ko) * 2006-01-06 2013-08-09 선오비온 파마슈티컬스 인코포레이티드 모노아민 재흡수 저해제로서의 시클로알킬아민
AU2009330355B2 (en) * 2008-12-16 2016-06-30 Sunovion Pharmaceuticals Inc. Triple reuptake inhibitors and methods of their use
US20140206740A1 (en) 2011-07-30 2014-07-24 Neurovance, Inc. Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
US12110296B2 (en) * 2018-10-17 2024-10-08 N.E. Chemcat Corporation Compound, and method for producing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2112548B1 (el) * 1970-11-09 1976-07-02 Eisai Co Ltd
US3917642A (en) * 1971-11-19 1975-11-04 Cities Service Co Brominated tricyclic imide flame retardants

Also Published As

Publication number Publication date
DK344083A (da) 1984-01-29
FI832716L (fi) 1984-01-29
PT77114B (en) 1986-01-27
ES524479A0 (es) 1985-04-01
FI832716A7 (fi) 1984-01-29
DK344083D0 (da) 1983-07-27
FI832716A0 (fi) 1983-07-27
IL69150A0 (en) 1983-11-30
JPS5933261A (ja) 1984-02-23
PT77114A (en) 1983-08-01
PH18828A (en) 1985-10-07
PL243202A1 (en) 1985-07-02
NO832734L (no) 1984-01-30
KR840005424A (ko) 1984-11-12
ZA835505B (en) 1984-04-25
AU1734183A (en) 1984-02-02
EP0100426A1 (en) 1984-02-15
ES8504125A1 (es) 1985-04-01

Similar Documents

Publication Publication Date Title
FR2525474B1 (el)
DE3347807A1 (el)
DK8504588A (el)
DE3348031A1 (el)
FR2519531B3 (el)
DE3249743A1 (el)
FR2519336B1 (el)
CH655653B (el)
CH655668B (el)
DE3347918A1 (el)
FR2519393B1 (el)
CH655441B (el)
FR2519606B3 (el)
CH655584B (el)
CH655407B (el)
FR2523429B3 (el)
FR2522185B1 (el)
CH655636B (el)
FR2519591B1 (el)
FR2519252B3 (el)
CH652562GA3 (el)
AU527338B1 (el)
FR2519507B1 (el)
FR2525881B3 (el)
FR2524664B3 (el)